Tai Ming-Hui相关文献与解析，生知库 | 链接生命科学的每一步

Amin, Moein; Harvey, Tucker; Pineda, Dan Michael; Tai, Ming-Hui; Shao, Qiujun; Brown, Brandon; Gadkari, Abhijit; Moss, Brandon; Conway, Devon S; Hersh, Carrie M

发表日期：2025

文献求助收藏

Real-world satisfaction and experience with injection and autoinjector device for ofatumumab indicated for multiple sclerosis

用于治疗多发性硬化症的奥法妥木单抗注射剂和自动注射器装置的实际满意度和使用经验

期刊:BMC Neurology

影响因子:2.2

doi:10.1186/s12883-024-04007-1

Ross, Amy Perrin; Nicholas, Jacqueline; Tai, Ming-Hui; Yeung, Stephen; Shaikh, Nazneen Fatima; Chen, Helen; Fernandes, Mariana; Cortright, Aaron; Hawkins, Kevin

COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review

美国接受奥法妥木单抗治疗的多发性硬化症患者接种新冠疫苗后的反应：一项医疗记录回顾研究

期刊:Neurology and Therapy

影响因子:4.8

doi:10.1007/s40120-024-00671-0

Dave, Rahul H; Crayton, Heidi; Miravalle, Augusto; Tai, Ming-Hui; Wyse, Kerri; Houghton, Katherine; Hitchens, Abby; Berkovich, Regina

Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

多发性骨髓瘤患者在不同治疗阶段接受达雷妥尤单抗治疗的治疗模式和疗效：一项真实世界病例回顾研究

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-021-08881-7

Atrash, Shebli; Thompson-Leduc, Philippe; Tai, Ming-Hui; Kaila, Shuchita; Gray, Kathleen; Ghelerter, Isabelle; Lafeuille, Marie-Hélène; Lefebvre, Patrick; Rossi, Adriana

Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

更正：多发性骨髓瘤患者在不同治疗阶段接受达雷妥尤单抗治疗的治疗模式和疗效：一项真实世界病例回顾研究

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-021-09015-9

Atrash, Shebli; Thompson-Leduc, Philippe; Tai, Ming-Hui; Kaila, Shuchita; Gray, Kathleen; Ghelerter, Isabelle; Lafeuille, Marie-Hélène; Lefebvre, Patrick; Rossi, Adriana

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins

接受高强度或中等强度他汀类药物治疗的患者的治疗模式和低密度脂蛋白胆固醇（LDL-C）目标达成情况

期刊:Clinical Research in Cardiology

影响因子:3.7

doi:10.1007/s00392-017-1193-z

Fox, Kathleen M; Tai, Ming-Hui; Kostev, Karel; Hatz, Maximilian; Qian, Yi; Laufs, Ulrich

代谢

发表日期：2018

文献求助收藏

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

美国遗传性血管性水肿患者的治疗模式和医疗资源利用情况

期刊:Orphanet Journal of Rare Diseases

影响因子:3.5

doi:10.1186/s13023-018-0922-3

Riedl, Marc A; Banerji, Aleena; Manning, Michael E; Burrell, Earl; Joshi, Namita; Patel, Dipen; Machnig, Thomas; Tai, Ming-Hui; Watson, Douglas J

发表日期：2018

文献求助收藏

STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.

STI571 可减少 TRAIL 诱导的结肠癌细胞凋亡：死亡受体激活 c-Abl 可导致应激激酶依赖性细胞死亡

期刊:Journal of Biomedical Science

影响因子:12.1

doi:10.1186/1423-0127-19-35

Huang Duen-Yi, Chao Yee, Tai Ming-Hui, Yu Yang-Hao, Lin Wan-Wan

Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro

体外实验表明，通过siRNA干扰敲低FoxM1可降低MHCC-97H细胞的增殖，诱导细胞周期阻滞并抑制细胞侵袭。

期刊:Acta Pharmacologica Sinica

影响因子:8.4

doi:10.1038/aps.2010.4

Wu, Qi-fei; Liu, Chang; Tai, Ming-hui; Liu, Dong; Lei, Lei; Wang, Rui-tao; Tian, Min; Lü, Yi

细胞生物学

发表日期：2010

文献求助收藏

Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice

奥法妥木单抗在临床实践中的真实世界疗效、持久性、耐受性和安全性

Real-world satisfaction and experience with injection and autoinjector device for ofatumumab indicated for multiple sclerosis

用于治疗多发性硬化症的奥法妥木单抗注射剂和自动注射器装置的实际满意度和使用经验

COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review

美国接受奥法妥木单抗治疗的多发性硬化症患者接种新冠疫苗后的反应：一项医疗记录回顾研究

Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

多发性骨髓瘤患者在不同治疗阶段接受达雷妥尤单抗治疗的治疗模式和疗效：一项真实世界病例回顾研究

Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

更正：多发性骨髓瘤患者在不同治疗阶段接受达雷妥尤单抗治疗的治疗模式和疗效：一项真实世界病例回顾研究

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins

接受高强度或中等强度他汀类药物治疗的患者的治疗模式和低密度脂蛋白胆固醇（LDL-C）目标达成情况

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

美国遗传性血管性水肿患者的治疗模式和医疗资源利用情况

STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.

STI571 可减少 TRAIL 诱导的结肠癌细胞凋亡：死亡受体激活 c-Abl 可导致应激激酶依赖性细胞死亡

Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro

体外实验表明，通过siRNA干扰敲低FoxM1可降低MHCC-97H细胞的增殖，诱导细胞周期阻滞并抑制细胞侵袭。